Drug Search Results
More Filters [+]

KN-015

Alternative Names: kn-015, kn015, kn 015
Latest Update: 2023-05-31
Latest Update Note: PubMed Publication

Product Description

KN015,the active substance recombinant human Follicle Stimulating Hormone(FSH) Fc fusion protein, which belongs to the pharmaceutical class gonadotropins. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT03192527)

Mechanisms of Action: FSH Inhibitor

Novel Mechanism: Yes

Modality: Fusion Protein

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Alphamab Jilin
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for KN-015

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Infertility, Female|Infertility, Male

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

KNJR-2017-001

P1

Unknown status

Infertility, Female|Infertility, Male

2019-03-01

Recent News Events